Kerberos Biopharma logo

Kerberos Biopharma

Kerberos Biopharma is an emerging biotechnology company targeting late stage cancer. The company is focused on research and development of highly potent small molecule antagonists of CX3CR1 and has identified and profiled an IND candidate with back-ups targeting Inflammatory Breast Cancer (IBC) as its first indication.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://kerberospharma.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address
3001 Market Street Suite 140,PA 19104
Philadelphia,
United States
Email
Contact Number
+1 215-762-8534

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/kerberos-biopharma” connections=”true” suffix=””]